Company

Quark Pharmaceuticals Inc.

Quark Pharmaceuticals develops RNA interference therapies for serious diseases.

About

Founded in 1993 and based in Fremont, US, Quark Pharmaceuticals develops RNAi-based therapies. Its candidates include QPI-1002 for renal protection and QPI-1007 for neurological disorders. The company raised USD 57.00 mn in a Series I round in October 2011, including investment from GoAhead Ventures.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in